BIRC5 and breast carcinoma: With use of a cutoff value for positivity determined as the mean absorbance + 2 SDs for healthy controls, 11/46 (23.9%) and 15/46 (32.6%) breast carcinoma patients were seropositive for survivin and livin, respectively.